EP Patent

EP4342459A1 — Pharmaceutical compositions of empagliflozin

Assigned to Galenicum Health SL · Expires 2024-03-27 · 2y expired

What this patent protects

The present invention relates to stable pharmaceutical compositions of empagliflozin, in the form of immediate release tablets and to a process for the manufacture of said stable pharmaceutical compositions.

USPTO Abstract

The present invention relates to stable pharmaceutical compositions of empagliflozin, in the form of immediate release tablets and to a process for the manufacture of said stable pharmaceutical compositions.

Drugs covered by this patent

Patent Metadata

Patent number
EP4342459A1
Jurisdiction
EP
Classification
—
Expires
2024-03-27
Drug substance claim
No
Drug product claim
No
Assignee
Galenicum Health SL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.